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Sir,
In the article ZD6474 reverses multidrug resistance by directly
inhibiting the function of P-glycoprotein in British Journal of Cancer
(2007) 97: 934–940, we indeed did not check the authenticity of the
cell lines MCF-7/ADR and KB, so, it is likely that MCF-7/ADR is not
an authentic variant of the MCF-7 breast carcinoma cell line and
that KB is not derived from oral carcinoma, although there
are numerous papers to mention that MCF-7/ADR is a variant of
the MCF-7 breast carcinoma cell line and KB is derived from oral
carcinoma. However, the authenticity of these cell lines does not
compromise the conclusion and scientific significance of this paper.
In our article, it is very clear that these cell lines (MCF-7/ADR and
KBV200) are drug resistant and their drug resistances are mediated
by P-glycoprotein. These characteristics of these cell lines are
enough to justify them to be used to study the pharmacologic effects
of ZD6474 and the mechanisms involved.
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